Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes

References

• Brooks H, Lebleu B, Vivès E. (2005). Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev, 57, 559–577.
   PubMed Web of Science ®Google Scholar
• Chan AT, Teo PM, Johnson PJ. (2002). Nasopharyngeal carcinoma. Ann Oncol, 13, 1007–1015.
   PubMed Web of Science ®Google Scholar
• Chang ET, Adami HO. (2006). The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 1765–1777.
   PubMed Web of Science ®Google Scholar
• Chang JT, Ko JY, Hong RL. (2004). Recent advances in the treatment of nasopharyngeal carcinoma. J Formos Med Assoc, 103, 496–510.
   PubMed Web of Science ®Google Scholar
• Chauhan A, Tikoo A, Kapur AK, Singh M. (2007). The taming of the cell penetrating domain of the HIV Tat: myths and realities. J Control Release, 117, 148–162.
   PubMed Web of Science ®Google Scholar
• Chou AS, Wang HY, Chen HC, Tsai MH, Chuang CK, Liao SK. (2009). Differential baseline and response profile to IFN-gamma gene transduction of IL-6/IL-6 receptor-alpha secretion discriminate primary tumors versus bone marrow metastases of nasopharyngeal carcinomas in culture. BMC Cancer, 9, 169.
   PubMedGoogle Scholar
• Chua DT, Sham JS, Au GK. (2005). A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma. Oral Oncol, 41, 589–595.
   PubMed Web of Science ®Google Scholar
• Conner SD, Schmid SL. (2003). Regulated portals of entry into the cell. Nature, 422, 37–44.
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Chaubal MV, Shorr R. (2008). Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Deliv Rev, 60, 757–767.
   PubMed Web of Science ®Google Scholar
• Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. (2009). Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release, 133, 11–17.
   PubMed Web of Science ®Google Scholar
• DeNittis AS, Liu L, Rosenthal DI, Machtay M. (2002). Nasopharyngeal carcinoma treated with external radiotherapy, brachytherapy, and concurrent/adjuvant chemotherapy. Am J Clin Oncol, 25, 93–95.
   PubMed Web of Science ®Google Scholar
• Fandi A, Cvitkovic E. (1995). Biology and treatment of nasopharyngeal cancer. Curr Opin Oncol, 7, 255–263.
   PubMedGoogle Scholar
• Feng S, Huang G. (2001). Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release, 71, 53–69.
   PubMed Web of Science ®Google Scholar
• Fonseca C, Simões S, Gaspar R. (2002). Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release, 83, 273–286.
   PubMed Web of Science ®Google Scholar
• Futaki S. (2005). Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv Drug Deliv Rev, 57, 547–558.
   PubMed Web of Science ®Google Scholar
• Gupta B, Levchenko TS, Torchilin VP. (2005). Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev, 57, 637–651.
   PubMed Web of Science ®Google Scholar
• Horwitz SB. (1994). Taxol (paclitaxel): mechanisms of action. Ann Oncol, 5 Suppl 6, S3–S6.
   PubMedGoogle Scholar
• Khalil IA, Kogure K, Futaki S, Harashima H. (2006). High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J Biol Chem, 281, 3544–3551.
   PubMed Web of Science ®Google Scholar
• Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. (2000). Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol, 18, 410–414.
   PubMed Web of Science ®Google Scholar
• Liang JF, Yang VC. (2005). Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity. Bioorg Med Chem Lett, 15, 5071–5075.
   PubMed Web of Science ®Google Scholar
• Liang XF, Wang HJ, Luo H, Tian H, Zhang BB, Hao LJ, Teng JI, Chang J. (2008). Characterization of novel multifunctional cationic polymeric liposomes formed from octadecyl quaternized carboxymethyl chitosan/cholesterol and drug encapsulation. Langmuir, 24, 7147–7153.
   PubMed Web of Science ®Google Scholar
• Liebmann J, Cook JA, Mitchell JB. (1993). Cremophor EL, solvent for paclitaxel, and toxicity. Lancet, 342, 1428.
   PubMed Web of Science ®Google Scholar
• Liebmann JE, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB. (1993). Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer, 68, 1104–1109.
   PubMed Web of Science ®Google Scholar
• Lin JJ, Chen JS, Huang SJ, Ko JH, Wang YM, Chen TL, Wang LF. (2009). Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials, 30, 5114–5124.
   PubMed Web of Science ®Google Scholar
• Liu J, Jiang X, Ashley C, Brinker CJ. (2009). Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. J Am Chem Soc, 131, 7567–7569.
   PubMed Web of Science ®Google Scholar
• McCarthy JS, Tannock IF, Degendorfer P, Panzarella T, Furlan M, Siu LL. (2002). A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. Oral Oncol, 38, 686–690.
   PubMed Web of Science ®Google Scholar
• Moon C, Kwon YM, Lee WK, Park YJ, Yang VC. (2007). In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. J Control Release, 124, 43–50.
   PubMed Web of Science ®Google Scholar
• Obara K, Ishihara M, Ozeki Y, Ishizuka T, Hayashi T, Nakamura S, Saito Y, Yura H, Matsui T, Hattori H, Takase B, Ishihara M, Kikuchi M, Maehara T. (2005). Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice. J Control Release, 110, 79–89.
   PubMed Web of Science ®Google Scholar
• Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. (1999). In vivo protein transduction: delivery of a biologically active protein into the mouse. Science, 285, 1569–1572.
   PubMed Web of Science ®Google Scholar
• Shiokawa T, Hattori Y, Kawano K, Ohguchi Y, Kawakami H, Toma K, Maitani Y. (2005). Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. Clin Cancer Res, 11, 2018–2025.
   PubMed Web of Science ®Google Scholar
• Spano JP, Busson P, Atlan D, Bourhis J, Pignon JP, Esteban C, Armand JP. (2003). Nasopharyngeal carcinomas: an update. Eur J Cancer, 39, 2121–2135.
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Rammohan R, Weissig V, Levchenko TS. (2001). TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA, 98, 8786–8791.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao P, Liang X, Gong X, Song T, Niu R, Chang J. (2010). Folate-PEG coated cationic modified chitosan–cholesterol liposomes for tumor-targeted drug delivery. Biomaterials, 31, 4129–4138.
   PubMed Web of Science ®Google Scholar
• Xie J, Wang CH. (2005). Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel. Pharm Res, 22, 2079–2090.
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen L, Gu W, Gao Y, Lin L, Zhang Z, Xi Y, Li Y. (2009). The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials, 30, 226–232.
   PubMed Web of Science ®Google Scholar
• Yang T, Choi MK, Cui FD, Kim JS, Chung SJ, Shim CK, Kim DD. (2007). Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release, 120, 169–177.
   PubMed Web of Science ®Google Scholar
• Zentner GM, Rathi R, Shih C, McRea JC, Seo MH, Oh H, Rhee BG, Mestecky J, Moldoveanu Z, Morgan M, Weitman S. (2001). Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release, 72, 203–215.
   PubMed Web of Science ®Google Scholar
• Zhao M, Kircher MF, Josephson L, Weissleder R. (2002). Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug Chem, 13, 840–844.
   PubMed Web of Science ®Google Scholar